Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
60.9%
% of THNR's 23 holdings also in OZEM
58.3%
% of OZEM's 25 holdings also in THNR
Overlap by Weight
Sector Drift (THNR minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.7% | 17.7% | 15.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 13.9% | 12.7% | 12.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.2% | 4.8% | 4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.7% | 5.2% | 4.7% |
 |
ROCHE HOLDING LTD | 4.7% | 6.5% | 4.7% |
Position Highlights (Non-Overlapping Exposures)
THNR Overweight Relative to OZEM
|
WEST PHARMACEUTICAL SERVICES | 5.1% |
|
THERMO FISHER SCIENTIFIC INC | 5.0% |
|
MERCK & CO. INC. | 4.7% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.6% |
|
MITSUBISHI CHEMICAL HOLDINGS | 3.5% |
 |
GERRESHEIMER AG | 1.9% |
|
BACHEM HOLDING AG | 1.3% |
|
NOVO-NORDISK A/S-SPONS ADR | 1.3% |
|
YPSOMED HOLDING AG-REG | 1.0% |
THNR Underweight Relative to OZEM
|
GILEAD SCIENCES INC | -2.7% |
|
REGENERON PHARMACEUTICALS | -2.4% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.4% |
 |
HANMI PHARM CO LTD | -2.3% |
|
SHIONOGI & CO LTD | -2.1% |
|
ELI LILLY & CO | -2.0% |
|
ALTIMMUNE, INC. | -2.0% |
|
ROCHE HOLDING LTD | -1.8% |
|
RHYTHM PHARMACEUTICALS, INC. | -1.8% |
|
SCHOLAR ROCK HOLDING CORP. | -1.6% |